67-72
Anthropometric indices, lipid profile, and lipopolysaccharide-binding protein levels in metabolic endotoxemia: A case-control study in Calabar Metropolis, Nigeria
Authors: Ekong Raymond Eworo1 , Edmund Richard Egbe2 , Zibril A. Okhormhe1 , Bassey K. Offor1 , Bassey Ikoedem Uduak1 , Andeshongkwe Dauda3

Number of views: 244
Objectives: To determine the anthropometric indices,
lipopolysaccharide-binding proteins (LBP), and lipid profile in
patients with metabolic endotoxemia.
Methods: The study comprised of 47 patients with metabolic
endotoxemia (the metabolic endotoxemia group) and 43 controls
(the control group). Patients in the metabolic endotoxemia group
were categorized further into three subgroups including the
normal weight group (n=8), the overweight group (n=12) and the
obese group (n=27). Height, weight, waist, and hip circumference
were measured, and waist-hip ratio (WHR) and body mass
index (BMI) were calculated. LBP was determined by ELISA
and total cholesterol, triglycerides, high density lipoprotein by
the respective enzymatic colorimetric methods. In addition,
low density lipoprotein and very low density lipoprotein were
determined by Friedewald’s formula.
Results: The mean waist circumference (WC), hip circumference
(HC), BMI, total cholesterol, low density lipoprotein, and LBP
of the metabolic endotoxemia group were significantly higher
(P<0.05) than those of the control group. WHR, TG, high density
lipoprotein and very low density lipoprotein of the metabolic
endotoxemia group were not significantly different (P>0.05) from
those of the control group. The mean WC, HC, WHR, and BMI
of the obese group with metabolic endotoxemia were significantly
higher (P<0.05) than those of the overweight group and the normal
weight group with metabolic endotoxemia. Significant positive
correlations were obtained between BMI and LBP (r=0.610,
P=0.001), total cholesterol and LBP (r=0.385, P=0.007), TG and
LBP (r=0.356, P=0.014) in patients with metabolic endotoxemia.
Conclusions: Metabolic endotoxemia arising from increased
circulating level of bacterial derive particles consequent to
perturbation in the gut microbial community and the elevated
serum level of LBP may precede the development of obesity,
characterized by dyslipidemia, dysregulation of gut energy
harvest, and metabolic energy imbalance.